Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis

BACKGROUND: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has been increasingly used over the last decade in patients with refractory cardiogenic shock. ECMO weaning can, however, be challenging and lead to circulatory failure and death. Recent data suggest a potential benefit of levos...

Descripción completa

Detalles Bibliográficos
Autores principales: Guilherme, Enrique, Jacquet-Lagrèze, Matthias, Pozzi, Matteo, Achana, Felix, Armoiry, Xavier, Fellahi, Jean-Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367381/
https://www.ncbi.nlm.nih.gov/pubmed/32677985
http://dx.doi.org/10.1186/s13054-020-03122-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367381/
https://www.ncbi.nlm.nih.gov/pubmed/32677985
http://dx.doi.org/10.1186/s13054-020-03122-y

Ejemplares similares